South Africa rethinks plans after variant evades AstraZeneca vaccine

SEMrush
South Africa paused its rollout of the Oxford/AstraZeneca vaccine as it might not be effective against the South African B.1.351 coronavirus variant – but it is still likely to limit the severity of covid-19
[automaticbacklinks]